Product Program year 2024 Source: CMS Open Payments

Tendyne Mitral Valve System

Device Structural Heart

Open in the dashboard

General payments

$26,480

226 payments

Research payments

$3,368,493

1,196 payments

Through program year 2024, $26,480 in general payments and $3,368,493 in research payments were reported against Tendyne Mitral Valve System (Structural Heart).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 Research $1,337,243 511
2023 Research $2,031,250 685
2020 General $24,127 203
2019 General $2,353 23

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $26,480 226 payments
Top recipients General payments · program year 2020
  1. Bruce Haik Cardiovascular Disease · Livingston, NJ $1,586 7% · 9 payments
  2. Mark Russo Thoracic Surgery (Cardiothoracic Vascular Surgery) · New Brunswick, NJ $1,340 6% · 8 payments
  3. Manminder Bhullar Interventional Cardiology · Fresno, CA $1,233 5% · 9 payments
  4. Ankur Sethi Interventional Cardiology · Oak Park, IL $1,139 5% · 7 payments
  5. Abdul Hakeem Cardiovascular Disease · Russellville, AR $1,132 5% · 7 payments

The top 5 of 30 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Cardiovascular Disease Internal Medicine $11,695 48% · 13 practitioners
  2. Interventional Cardiology Internal Medicine $7,193 30% · 8 practitioners
  3. Thoracic Surgery (Cardiothoracic Vascular Surgery) $4,867 20% · 7 practitioners
  4. Internal Medicine $296 1% · 1 practitioner
  5. Hospitalist $75 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. New Jersey $6,310 26% · 5 recipients
  2. California $5,617 23% · 6 recipients
  3. Georgia $4,600 19% · 5 recipients
  4. Ohio $2,330 10% · 5 recipients
  5. Pennsylvania $1,584 7% · 2 recipients

The top 5 of 10 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

226 general · 1,196 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record